Bin Tean Teh is a Senior Principal Investigator at the Institute of Molecular and Cell Biology and Senior Group Leader at the Genome Institute of Singapore at A*STAR. He is also jointly the Deputy CEO for Research at the National Cancer Centre Singapore and a Professor at Duke-NUS Medical School. He obtained his MD from the University of Queensland, Australia and his PhD from the Karolinska Institute, Sweden. In 2010, he received the prestigious Singapore Translational Research Investigator (STaR) Award and relocated to Singapore to serve as the SingHealth Group Director for Translational Research. For the last decade, his laboratory has been focusing on Asian-prevalent cancers leading to seminal discoveries in the field of herbal carcinogen-related cancers, breast fibroepithelial tumours, renal cell carcinoma and cholangiocarcinoma.
